SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
CFO Keith A. Goldan sold $43K of Syndax Pharmaceuticals, Inc.
Sold$42,931
$20.62Price
2,082Shares
−1%Stake
What SNDX did after the filing
- The stock from Mon, Feb 9 open, $20.92
- +14.8%
- S&P 500, same days
- −5.3%
Measured over 30 trading days, to the Mar 24 close.
Traded Fri, Feb 6. Filed Fri, Feb 6, 5:53 PM ET, after the close. Returns use the Feb 9 open and the Mar 24 close. Not investment advice.